Arcturus Therapeutics Holdings Inc. 8-K Summary
Business Context and Reporting Period
This Form 8-K reports on the results of the 2025 Annual Meeting of Stockholders held by Arcturus Therapeutics Holdings Inc. on June 6, 2025. The company is incorporated in Delaware and its common stock trades on The NASDAQ Stock Market LLC under the symbol "ARCT".
Key Financial Metrics
This filing is a current report regarding corporate governance and does not contain financial performance data. The text does not provide values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes and Voting Results
A quorum was established with 22,006,524 shares present out of 27,120,603 shares entitled to vote. Stockholders approved three proposals:
- Proposal 1 (Election of Directors): All nine nominees were elected to the Board of Directors. The nominees received significant support, with "For" votes ranging from approximately 18.5 million to 19.0 million shares. Broker non-votes totaled 2,883,662 shares for all director nominees.
- Proposal 2 (Say-on-Pay): The non-binding advisory resolution approving named executive officer compensation was approved. Votes were 18,472,131 "For", 586,006 "Against", and 64,724 "Abstain".
- Proposal 3 (Auditor Ratification): The appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025, was ratified. Votes were 21,971,168 "For", 30,589 "Against", and 4,767 "Abstain".
Guidance, Outlook, and Risks
The filing does not contain management commentary, financial guidance, outlook, or discussions of risks and contingencies. It strictly reports the procedural outcomes of the annual meeting.
Key Facts for Investor Verification
- Verify the full list of elected directors and their tenure terms in the definitive proxy statement filed on April 25, 2025.
- Confirm the specific compensation details for named executive officers referenced in the approved "say-on-pay" proposal.
- Review the upcoming fiscal year 2025 financial reports for the first time since the auditor ratification to assess financial health.